previous
| CSGID ID | Priority | Locus Tag | NCBI GI | Gene Name |
Common Name | Sequence Length |
Comment | Project | Homolog PDB ID |
Homolog Sequence Identity |
Target Organism | TIGR Main Role | TIGR Subrole | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| IDP00027 | 1 | BA_0400 | 30253935 | tellurium resistance protein | 194 | Virulence | October 2007 | 2QNG | 24.7% | Bacillus anthracis | Cellular processes | Toxin production and resistance | ||||||||||||||||||
| IDP01143 | 1 | BA_4194 | 30258698 | 2,3,4,5-tetrahydropyridine-2-carboxylate... | 240 | Drug Target Function | March 2008 | 1HV9 | 68.7% | Bacillus anthracis | Amino acid biosynthesis | Aspartate family | ||||||||||||||||||
| IDP01186 | 1 | BA_0298 | 81584380 | Bifunctional purine biosynthesis protein... | 511 | Conserved Gene / Pathway | March 2008 | 1G8M | 40.1% | Bacillus anthracis | Purines, pyrimidines, nucleosides, and nucleotides | Purine ribonucleotide biosynthesis | ||||||||||||||||||
| IDP01170 | 1 | BA_0165 | 30253674 | prolyl oligopeptidase family protein, pu... | 654 | Drug Target Function | March 2008 | 1J2E | 11.6% | Bacillus anthracis | Protein fate | Degradation of proteins, peptides, and glycopeptides | ||||||||||||||||||
| IDP00043 | 1 | BA_2629 | 30257246 | acetyltransferase, CYSE/LACA/LPXA/NODL f... | 210 | Virulence | October 2007 | 1G95 | 59.5% | Bacillus anthracis | Cellular processes | Toxin production and resistance | ||||||||||||||||||
| IDP00036 | 1 | BA_1840 | 30256110 | fibronectin-binding protein, putative | 213 | Virulence | October 2007 | Bacillus anthracis | Cellular processes | Pathogenesis | ||||||||||||||||||||
| IDP00054 | 1 | BA_3600 | 30258128 | acetyltransferase, CYSE/LACA/LPXA/NODL f... | 185 | Virulence | October 2007 | 1G95 | 42.2% | Bacillus anthracis | Cellular processes | Toxin production and resistance | ||||||||||||||||||
| IDP00046 | 1 | BA_3165 | 30257736 | bromoperoxidase | 278 | Virulence | October 2007 | 1A7U | 49.3% | Bacillus anthracis | Cellular processes | Toxin production and resistance | ||||||||||||||||||
| IDP01128 | 1 | BA_4595 | 30259095 | iron compound ABC transporter, ATP-bindi... | 272 | Conserved Gene / Pathway | March 2008 | 1B0U | 29.8% | Bacillus anthracis | Transport and binding proteins | Cations and iron carrying compounds | ||||||||||||||||||
| IDP01174 | 1 | BA_2823 | 30257425 | hypothetical protein BA_2823 | 375 | Drug Target Function | March 2008 | Bacillus anthracis | ||||||||||||||||||||||
| IDP01175 | 1 | BA_2825 | 30257427 | peptidase M3 family protein | 548 | Drug Target Function | March 2008 | 2H1J | 23.4% | Bacillus anthracis | Protein fate | Degradation of proteins, peptides, and glycopeptides | ||||||||||||||||||
| IDP01146 | 1 | BA_0235 | 30253735 | oligopeptide ABC transporter, ATP-bindin... | 336 | Conserved Gene / Pathway | March 2008 | 1B0U | 26.8% | Bacillus anthracis | Transport and binding proteins | Amino acids, peptides and amines | ||||||||||||||||||
| IDP01153 | 1 | BA_5712 | 30260159 | yycI protein | 280 | Conserved Gene / Pathway | March 2008 | 2O3O | 28.2% | Bacillus anthracis | Cellular processes | Cell division | ||||||||||||||||||
| IDP01122 | 1 | BA_4045 | 30258552 | ftsZ | cell division protein FtsZ | 386 | Conserved Gene / Pathway | March 2008 | 1FSZ | 78.8% | Bacillus anthracis | Cellular processes | Cell division | |||||||||||||||||
| IDP01138 | 1 | BA_4230 | 30258733 | alpha-amylase | 586 | Drug Target Function | March 2008 | 1BLI | 61.3% | Bacillus anthracis | Energy metabolism | Biosynthesis and degradation of polysaccharides | ||||||||||||||||||
| IDP01114 | 1 | BA_4901 | 38502945 | Septation ring formation regulator ezrA | 570 | Conserved Gene / Pathway | March 2008 | Bacillus anthracis | Cellular processes | Cell division | ||||||||||||||||||||
| IDP01155 | 1 | BA_0312 | 81837905 | Methionine import ATP-binding protein me... | 339 | Conserved Gene / Pathway | March 2008 | 1B0U | 49.3% | Bacillus anthracis | Transport and binding proteins | Unknown substrate | ||||||||||||||||||
| IDP01178 | 1 | BA_0008 | 30253523 | guaB | inosine-5'-monophosphate dehydrogenase | 487 | Conserved Gene / Pathway | March 2008 | 1AK5 | 69.6% | Bacillus anthracis | Purines, pyrimidines, nucleosides, and nucleotides | Purine ribonucleotide biosynthesis | |||||||||||||||||
| IDP00025 | 1 | BA_0285 | 30253779 | bacitracin ABC transporter, ATP-binding ... | 309 | Virulence | October 2007 | 1B0U | 31.4% | Bacillus anthracis | Cellular processes | Toxin production and resistance | ||||||||||||||||||
| IDP01180 | 1 | BA_0049 | 46396353 | Ribose-phosphate pyrophosphokinase (RPPK... | 317 | Conserved Gene / Pathway | March 2008 | 1DKR | 85.5% | Bacillus anthracis | Purines, pyrimidines, nucleosides, and nucleotides | Purine ribonucleotide biosynthesis | ||||||||||||||||||
| IDP01110 | 1 | BA_1229 | 30255178 | rfbC | dTDP-4-dehydrorhamnose 3,5-epimerase | 181 | Conserved Gene / Pathway | March 2008 | 1DZR | 49.2% | Bacillus anthracis | Cell envelope | Biosynthesis and degradation of surface polysaccharides and lipopolysaccharides | |||||||||||||||||
| IDP01188 | 1 | BA_0502 | 30254030 | penicillin-binding protein, putative | 412 | Drug Target Function | March 2008 | 1BLS | 21.8% | Bacillus anthracis | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | ||||||||||||||||||
| IDP00032 | 1 | BA_1221 | 30255171 | bacteriocin O-metyltransferase, putative... | 281 | Virulence | October 2007 | Bacillus anthracis | Cellular processes | Toxin production and resistance | ||||||||||||||||||||
| IDP01187 | 1 | BA_0485 | 30254015 | prophage LambdaBa04, glycosyl hydrolase,... | 265 | Conserved Gene / Pathway | March 2008 | 2NW0 | 51.7% | Bacillus anthracis | Cell envelope | Biosynthesis and degradation of surface polysaccharides and lipopolysaccharides | ||||||||||||||||||
| IDP01256 | 1 | BA_1232 | 30255181 | fabI | enoyl-(acyl-carrier-protein) reductase | 256 | Drug Target Function | March 2008 | 1AE1 | 100% | Bacillus anthracis | Fatty acid and phospholipid metabolism | Biosynthesis | |||||||||||||||||
| IDP01179 | 1 | BA_0048 | 81583548 | Bifunctional protein glmU [Includes: UDP... | 459 | Drug Target Function | March 2008 | 1FWY | 51.6% | Bacillus anthracis | Cell envelope | Biosynthesis and degradation of surface polysaccharides and lipopolysaccharides | ||||||||||||||||||
| IDP00029 | 1 | BA_0404 | 30253939 | tellurite resistance protein, putative | 360 | Virulence | October 2007 | Bacillus anthracis | Cellular processes | Toxin production and resistance | ||||||||||||||||||||
| IDP00062 | 1 | BA_4511 | 50400989 | 4-hydroxy-3-methylbut-2-enyl diphosphate... | 316 | Virulence | October 2007 | Bacillus anthracis | Cellular processes | Toxin production and resistance | ||||||||||||||||||||
| IDP01115 | 1 | BA_1901 | 30256561 | xaa-pro aminopeptidase, putative | 427 | Drug Target Function | March 2008 | 1A16 | 31.6% | Bacillus anthracis | Protein fate | Degradation of proteins, peptides, and glycopeptides | ||||||||||||||||||
| IDP01133 | 1 | BA_1353 | 30255290 | oligoendopeptidase F, putative | 564 | Drug Target Function | March 2008 | 2H1J | 67.4% | Bacillus anthracis | Protein fate | Degradation of proteins, peptides, and glycopeptides | ||||||||||||||||||
| IDP01190 | 1 | BA_0872 | 30254622 | N-acetylmuramoyl-L-alanine amidase, fami... | 348 | Drug Target Function | March 2008 | 1YB0 | 16.7% | Bacillus anthracis | Cell envelope | Biosynthesis and degradation of surface polysaccharides and lipopolysaccharides | ||||||||||||||||||
| IDP01125 | 1 | BA_5175 | 30259658 | ABC transporter, ATP-binding protein | 219 | Conserved Gene / Pathway | March 2008 | 1B0U | 34.7% | Bacillus anthracis | Transport and binding proteins | Unknown substrate | ||||||||||||||||||
| IDP00040 | 1 | BA_2042 | 46395770 | Metallothiol transferase fosB 1 (Fosfomy... | 138 | Virulence | October 2007 | 1LQK | 42.8% | Bacillus anthracis | Cellular processes | Toxin production and resistance | ||||||||||||||||||
| IDP01201 | 1 | BA_1826 | 34098434 | 3-oxoacyl-[acyl-carrier-protein] synthas... | 327 | Drug Target Function | March 2008 | 1BI5 | 40.7% | Bacillus anthracis | Fatty acid and phospholipid metabolism | Biosynthesis | ||||||||||||||||||
| IDP01112 | 1 | BA_2064 | 30256713 | csaA | chaperone CsaA | 109 | Conserved Gene / Pathway | March 2008 | 1E7Z | 72.5% | Bacillus anthracis | Protein fate | Protein and peptide secretion and trafficking | |||||||||||||||||
| IDP01108 | 1 | BA_3860 | 30258377 | copper-ion-binding protein | 68 | Conserved Gene / Pathway | March 2008 | 1AFI | 61.8% | Bacillus anthracis | Transport and binding proteins | Cations and iron carrying compounds | ||||||||||||||||||
| IDP00010 | 1 | BA_2144 | 30256791 | uroporphyrin-III C-methyltransferase, pu... | 474 | Drug Target Homolog | October 2007 | 1CBF | 24.1% | Bacillus anthracis | Biosynthesis of cofactors, prosthetic groups, and carriers | Heme, porphyrin, and cobalamin | ||||||||||||||||||
| IDP01238 | 1 | BA_5635 | 30260086 | lipoate-protein ligase A, putative | 281 | Drug Target Function | March 2008 | 2P0L | 60.1% | Bacillus anthracis | Protein fate | Protein modification and repair | ||||||||||||||||||
| IDP00055 | 1 | BA_3696 | 30258217 | blasticidin S deaminase, putative | 142 | Virulence | October 2007 | 3B8F | 99.3% | Bacillus anthracis | Cellular processes | Toxin production and resistance | ||||||||||||||||||
| IDP00017 | 1 | BA_4333 | 81581445 | ribBA | Riboflavin biosynthesis protein ribBA [I... | 397 | Drug Target Homolog | October 2007 | 1G57 | 27% | Bacillus anthracis | Biosynthesis of cofactors, prosthetic groups, and carriers | Riboflavin, FMN, and FAD | |||||||||||||||||
| IDP01247 | 1 | BA_3214 | 30257780 | penicillin-binding protein, putative | 691 | Drug Target Function | March 2008 | 1BLS | 14.2% | Bacillus anthracis | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | ||||||||||||||||||
| IDP01121 | 1 | BA_1933 | 30256591 | branched-chain amino acid ABC transporte... | 257 | Conserved Gene / Pathway | March 2008 | 1B0U | 31.1% | Bacillus anthracis | Transport and binding proteins | Amino acids, peptides and amines | ||||||||||||||||||
| IDP01236 | 1 | BA_5514 | 30259974 | glycosyl transferase, group 1 family pro... | 550 | Drug Target Function | March 2008 | Bacillus anthracis | Cell envelope | Biosynthesis and degradation of surface polysaccharides and lipopolysaccharides | ||||||||||||||||||||
| IDP01151 | 1 | BA_5433 | 30259901 | UDP-N-acetylglucosamine 2-epimerase | 371 | Conserved Gene / Pathway | March 2008 | 1F6D | 99.2% | Bacillus anthracis | Cell envelope | Biosynthesis and degradation of surface polysaccharides and lipopolysaccharides | ||||||||||||||||||
| IDP00065 | 1 | BA_5409 | 30259882 | macrolide efflux pump, putative | 544 | Virulence | October 2007 | 1B0U | 24.1% | Bacillus anthracis | Cellular processes | Toxin production and resistance | ||||||||||||||||||
| IDP00001 | 1 | BA_4599 | 30259099 | aldehyde-alcohol dehydrogenase | 867 | Drug Target Homolog | October 2007 | 1A4S | 15% | Bacillus anthracis | Energy metabolism | Fermentation | ||||||||||||||||||
| IDP01161 | 1 | BA_4997 | 30259489 | ABC transporter, ATP-binding protein | 253 | Conserved Gene / Pathway | March 2008 | 1B0U | 38.3% | Bacillus anthracis | Transport and binding proteins | Unknown substrate | ||||||||||||||||||
| IDP01103 | 1 | BA_1387 | 47605671 | D-alanine--poly(phosphoribitol) ligase s... | 79 | Drug Target Function | March 2008 | 1DV5 | 45.6% | Bacillus anthracis | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | ||||||||||||||||||
| IDP01160 | 1 | BA_4774 | 30259261 | bacitracin ABC transporter, ATP-binding ... | 307 | Conserved Gene / Pathway | March 2008 | 1F3O | 25.7% | Bacillus anthracis | Transport and binding proteins | Other | ||||||||||||||||||
| IDP01203 | 1 | BA_2083 | 30256732 | glycosyltransferase, MGT family | 402 | Conserved Gene / Pathway | March 2008 | 2ACV | 27.6% | Bacillus anthracis | Cell envelope | Biosynthesis and degradation of surface polysaccharides and lipopolysaccharides | ||||||||||||||||||
| IDP01242 | 1 | BA_1572 | 30255873 | penicillin-binding protein | 897 | Drug Target Function | March 2008 | 1FNF | 27.9% | Bacillus anthracis | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | ||||||||||||||||||
| IDP00016 | 1 | BA_4053 | 46576983 | UDP-N-acetylmuramoyl-L-alanyl-D-glutamat... | 491 | Drug Target Homolog | October 2007 | 1E8C | 35% | Bacillus anthracis | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | ||||||||||||||||||
| IDP01113 | 1 | BA_0368 | 30253903 | amino acid ABC transporter, ATP-binding ... | 240 | Conserved Gene / Pathway | March 2008 | 1B0U | 65.4% | Bacillus anthracis | Transport and binding proteins | Amino acids, peptides and amines | ||||||||||||||||||
| IDP00064 | 1 | BA_5200 | 30259683 | transcriptional activator tipA, putative... | 243 | Virulence | October 2007 | 1EXI | 24.7% | Bacillus anthracis | Cellular processes | Toxin production and resistance | ||||||||||||||||||
| IDP00033 | 1 | BA_1295 | 30255240 | immune inhibitor A metalloprotease | 795 | Virulence | October 2007 | Bacillus anthracis | Cellular processes | Toxin production and resistance | ||||||||||||||||||||
| IDP01199 | 1 | BA_1537 | 67460530 | Chorismate synthase 1 (5-enolpyruvylshik... | 390 | Drug Target Function | March 2008 | 1Q1L | 59% | Bacillus anthracis | Amino acid biosynthesis | Aromatic amino acid family | ||||||||||||||||||
| IDP00005 | 1 | BA_0552 | 30254078 | internalin, putative | 1070 | Virulence/Drug Target Homolog | October 2007 | 1D0B | 13.5% | Bacillus anthracis | Cellular processes | Pathogenesis | ||||||||||||||||||
| IDP01257 | 1 | BA_5677 | 30260125 | glycosyl transferase, group 2 family pro... | 267 | Drug Target Function | March 2008 | 3BCV | 11.2% | Bacillus anthracis | Cell envelope | Biosynthesis and degradation of surface polysaccharides and lipopolysaccharides | ||||||||||||||||||
| IDP00138 | 1 | BA_4159 | 30258665 | conserved hypothetical protein | 95 | October 2007 | 2GBO | 56.8% | Bacillus anthracis | Purines, pyrimidines, nucleosides, and nucleotides | Nucleotide and nucleoside interconversions | |||||||||||||||||||
| IDP00015 | 1 | BA_4048 | 47605856 | UDP-N-acetylenolpyruvoylglucosamine redu... | 301 | Drug Target Homolog | October 2007 | 1HSK | 39.5% | Bacillus anthracis | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | ||||||||||||||||||
| IDP00049 | 1 | BA_3355 | 30257898 | thiol-activated cytolysin | 512 | Virulence | October 2007 | 1M3I | 67.4% | Bacillus anthracis | Cellular processes | Toxin production and resistance | ||||||||||||||||||
| IDP01106 | 1 | BA_1846 | 30256116 | msrA-1 | peptide methionine sulfoxide reductase | 178 | Conserved Gene / Pathway | March 2008 | 1FF3 | 36% | Bacillus anthracis | Protein fate | Protein modification and repair | |||||||||||||||||
| IDP01218 | 1 | BA_3712 | 73919984 | Histidine ammonia-lyase (Histidase) | 505 | Drug Target Function | March 2008 | 1B8F | 42.2% | Bacillus anthracis | Energy metabolism | Amino acids and amines | ||||||||||||||||||
| IDP01234 | 1 | BA_5509 | 30259969 | UDP-N-acetylglucosamine 2-epimerase | 371 | Drug Target Function | March 2008 | 1F6D | 100% | Bacillus anthracis | Cell envelope | Biosynthesis and degradation of surface polysaccharides and lipopolysaccharides | ||||||||||||||||||
| IDP01131 | 1 | BA_5381 | 30259854 | ptsH-2 | phosphocarrier protein HPr | 82 | Conserved Gene / Pathway | March 2008 | 1CM2 | 73.2% | Bacillus anthracis | Transport and binding proteins | Carbohydrates, organic alcohols, and acids | |||||||||||||||||
| IDP01132 | 1 | BA_4703 | 30259197 | loN2 | ATP-dependent protease LA | 557 | Drug Target Function | March 2008 | 1IQP | 15.4% | Bacillus anthracis | Protein fate | Degradation of proteins, peptides, and glycopeptides | |||||||||||||||||
| IDP01221 | 1 | BA_3990 | 30258499 | fabD | malonyl CoA-acyl carrier protein transac... | 314 | Drug Target Function | March 2008 | 1MLA | 44.9% | Bacillus anthracis | Fatty acid and phospholipid metabolism | Biosynthesis | |||||||||||||||||
| IDP01243 | 1 | BA_2345 | 30256982 | penicillin-binding protein 1A | 820 | Drug Target Function | March 2008 | 1MWR | 29.5% | Bacillus anthracis | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | ||||||||||||||||||
| IDP01196 | 1 | BA_1248 | 30255197 | trpE | anthranilate synthase component I | 471 | Drug Target Function | March 2008 | 1I1Q | 38.4% | Bacillus anthracis | Amino acid biosynthesis | Aromatic amino acid family | |||||||||||||||||
| IDP00048 | 1 | BA_3330 | 30257875 | beta-lactam antibiotic acylase family pr... | 796 | Virulence | October 2007 | 1AI4 | 22.2% | Bacillus anthracis | Cellular processes | Toxin production and resistance | ||||||||||||||||||
| IDP01156 | 1 | BA_0798 | 30254389 | ABC transporter, ATP-binding protein | 224 | Conserved Gene / Pathway | March 2008 | 1B0U | 50.9% | Bacillus anthracis | Transport and binding proteins | Unknown substrate | ||||||||||||||||||
| IDP01223 | 1 | BA_4051 | 60390084 | UDP-N-acetylmuramoylalanine--D-glutamate... | 450 | Conserved Gene / Pathway | March 2008 | 1E0D | 34.4% | Bacillus anthracis | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | ||||||||||||||||||
| IDP01213 | 1 | BA_3251 | 30257808 | 3-oxoacyl-(acyl-carrier-protein) synthas... | 329 | Drug Target Function | March 2008 | 1BI5 | 34.7% | Bacillus anthracis | Fatty acid and phospholipid metabolism | Biosynthesis | ||||||||||||||||||
| IDP01148 | 1 | BA_1159 | 30254878 | katB | catalase | 488 | Conserved Gene / Pathway | March 2008 | 1A4E | 65.2% | Bacillus anthracis | Cellular processes | Detoxification | |||||||||||||||||